SCHEMBL4507587

SCHEMBL4507587

Cc1cc(C)nc(NC(=O)c2cc(COc3cc(Cl)ccc3Cl)ccn2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.59
MAPT P10636 5/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
KDM4E B2RXH2 3/20 0.59
PKM P14618 1/20 0.59
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 2/20 0.51
THRB P10828 1/20 0.48
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
HPGD P15428 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALDH1A1 P00352 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
CASP3 P42574 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496717 0.90 MAPT (0.60) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4500386 0.89 MAPT (0.74) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4501168 0.84 MAPT (0.60) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4492876 0.84 MAPT (0.52) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4500960 0.83 SMN1; SMN2 (0.58) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4502419 0.82 MAPT (0.59) SMN1; SMN2MAPTMEN1KMT2AKDM4E
Trifluoroacetic Acid SCHEMBL4508117 0.80 SMN1; SMN2 (0.61) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4516088 0.79 SMN1; SMN2 (0.48) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4513766 0.77 MAPT (0.48) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL4491985 0.77 MRGPRX4 (0.62) SMN1; SMN2MAPTMEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS SMN1; SMN2 2075/4885MAPT 4022/4885MEN1 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.